BS is a patient with T2D considering treatment with an injectable GLP-1 RA. While BS is not opposed to injections, he would prefer a single-dose injection device, so he does not have to deal with pen needles. Which of the following products is available commercially in a single-dose pen device that does not require use of pen needles? A. Liraglutide B. Dulaglutide C. Injectable semaglutide D. Exenatide
[Answered]: BS is a patient with T2D considering treatment…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.
